Abstract

Chronic myelomonocytic leukemia is a myeloid stem cell disease characterized by an abnormal production and accumulation of monocytic cells in association with other signs of myeloproliferation. Extramedullary manifestations of CMML are common and can affect the spleen, liver skin, and lymph nodes. However, otologic manifestations are extremely rare and could have occurred from either direct leukemic infiltration, hemorrhage of the cochlea, labyrinth, leukostasis, or infection. There is no standard treatment protocol for sensorineural hearing loss in CMML patients. More research is needed to improve the understanding of the pathogenesis of this condition, in order to provide better treatment options.

Full Text

Published Version
Open DOI Link

Topics from this Paper

  • Chronic Myelomonocytic Leukemia
  • Case Of Sudden Hearing Loss
  • CMML Patients
  • Otologic Manifestations
  • Abnormal Production
    • + Show 5 more

Create a personalized feed of these topics

Get Started

Get access to 115M+ research papers

Discover from 40M+ Open access, 2M+ Pre-prints, 9.5M Topics and 32K+ Journals.

Sign Up Now! It's FREE

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

A Case of Sudden Hearing Loss Involving Vertigo in Childhood
  • Practica oto-rhino-laryngologica. Suppl.
  • Jan 1, 2016
Relevant
Not Relevant
[Clinical features of sudden sensorineural hearing loss accompanied with inner ear hemorrhage].
  • Chinese journal of otorhinolaryngology head and neck surgery
  • Dec 1, 2015
Relevant
Not Relevant
A case of sudden hearing loss during treatment with decitabine for chronic myelomonocytic leukemia.
  • Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
  • Feb 20, 2014
Relevant
Not Relevant
A Case of Bilateral Sudden Hearing Loss and Tinnitus after Salicylate Intoxication
  • Korean Journal of Audiology
  • Apr 1, 2013
Relevant
Not Relevant
Characteristics of Granulocyte‐Macrophage Colony Formation in Chronic Myelomonocytic Leukemia: A Comparative Study with Other Myelodysplastic and Myeloproliferative Disorders
  • Japanese Journal of Cancer Research
  • Aug 1, 1990
Relevant
Not Relevant
Symptoms: Sudden Hearing Loss and Facial Paralysis
  • The Hearing Journal
  • May 1, 2021
Relevant
Not Relevant
Chronic Myelomonocytic Leukemia Is Associated with More Frequent and More Rapid Progression to Acute Myeloid Leukemia and Shorter Survival Than Myelodysplastic Syndrome, but Is Less Frequently Treated: Analysis of Surveillance Epidemiology and End Results Data Linked to Medicare Enrollment Claims
  • Blood
  • Nov 18, 2011
Relevant
Not Relevant
Correction to: A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia
  • Annals of Hematology
  • Nov 3, 2023
Relevant
Not Relevant
High Rates of Atherosclerotic Disease-Related Mortality in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Patients Associated with TET2-Mutations
  • Blood
  • Dec 7, 2017
Relevant
Not Relevant
Epidemiology of Hearing Loss
  • International Journal of Audiology
  • Sep 1, 1973
Relevant
Not Relevant
Phase 1b Trial of Anti-Immunoglobulin-like Transcript 3 Monoclonal Antibody MK-0482 Monotherapy in Relapsed/Refractory Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia
  • Blood
  • Nov 15, 2022
Relevant
Not Relevant
Sudden Sensorineural Hearing Loss
  • Otolaryngologic Clinics of North America
  • Jun 1, 1996
Relevant
Not Relevant
Sudden hearing loss in acoustic neuroma patients
  • Otolaryngology–Head and Neck Surgery
  • Jul 1, 1995
Relevant
Not Relevant
Sudden hearing loss in acoustic neuroma patients
  • Otolaryngology - Head and Neck Surgery
  • Jul 1, 1995
Relevant
Not Relevant
Five cases of sudden hearing loss of presumed vascular origin
  • Medical Journal of Australia
  • Aug 1, 1987
Relevant
Not Relevant
READ MORE FROM

Annals of hematology

The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Open Access
Just Published
  • Annals of hematology
  • Nov 28, 2023
Relevant
Not Relevant
Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab.
Just Published
  • Annals of hematology
  • Nov 27, 2023
Relevant
Not Relevant
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study.
Just Published
  • Annals of hematology
  • Nov 27, 2023
Relevant
Not Relevant
Role and application of chemokine CXCL13 in central nervous system lymphoma.
Just Published
  • Annals of hematology
  • Nov 27, 2023
Relevant
Not Relevant
Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.
  • Annals of hematology
  • Nov 18, 2023
Relevant
Not Relevant
Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia.
  • Annals of hematology
  • Nov 17, 2023
Relevant
Not Relevant
Screening results and mutation frequency analysis of G6PD deficiency in 1,291,274 newborns in Huizhou, China: a twenty-year experience.
  • Annals of hematology
  • Nov 16, 2023
Relevant
Not Relevant
Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia-a national inpatient sample analysis.
  • Annals of hematology
  • Oct 27, 2023
Relevant
Not Relevant
Unicentric Castleman's disease presenting as amyloid A cardiac amyloidosis: a case report.
  • Annals of hematology
  • Oct 26, 2023
Relevant
Not Relevant
Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‐cell lymphoma: results of a multicentric prospective cohort study.
  • Annals of hematology
  • Oct 26, 2023
Relevant
Not Relevant